Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
09/01/2010 | CN101816723A Sobering up and liver protecting Chinese medicinal preparation and preparation method thereof |
09/01/2010 | CN101816712A Chinese medicinal composition for treating trigeminal neuralgia |
09/01/2010 | CN101816691A Gensenosides osmotic pump capsule and preparation method thereof |
09/01/2010 | CN101816690A Gensenoside double-layer osmotic pump tablet and preparation method thereof |
09/01/2010 | CN101816673A Medicinal preparation containing levodopa and cytidine diphosphate and application thereof in treating parkinson diseases |
09/01/2010 | CN101816657A Process for preparing vinegar powder soft capsules |
09/01/2010 | CN101816656A Formula of vinegar powder soft capsules |
09/01/2010 | CN101816655A Medicinal preparation containing repaglinide and ligustrazine and application thereof in diabetic complications |
09/01/2010 | CN101816654A Medicinal combination of nalmefene hydrochloride and polyvinyl pyrrolidone and preparation method thereof |
09/01/2010 | CN101816313A Chinese medicinal camphor ball |
09/01/2010 | CN101433545B Use of bioflavanoid or polyphenolic substance for treating parkinson's disease |
09/01/2010 | CN101313908B Composition for treating autonomic nerve disorder, preparation and uses thereof |
09/01/2010 | CN101292972B Use of 3,4-dihydroxy coffee acyl group tartaric acid in preparing medicaments for treating dementia diseases |
09/01/2010 | CN101288761B Chinese tmedicine preparation for treating depression and its preparation method |
09/01/2010 | CN101269179B Traditional Chinese medicine preparation for treating senile dementia and preparation method thereof |
09/01/2010 | CN101264058B Huperzine A and its derivative or salts sustained-release nanometer granule and preparing method thereof |
09/01/2010 | CN101255422B siRNA sequence suppressing expression of bax gene |
09/01/2010 | CN101209266B Compound sobering-up agent |
09/01/2010 | CN101204378B Memantine hydrochloride oral medicine compound and its preparation method |
09/01/2010 | CN101190327B 'Kanlijiaobuye' a kind of traditional Chinese medicinal oral liquid |
09/01/2010 | CN101085062B Medicine for curing parkinson's disease and its preparing method |
09/01/2010 | CN101057678B Composition containing natural plant extraction or monomer |
08/31/2010 | US7786311 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
08/31/2010 | US7786177 Phenylalanine enamide derivatives |
08/31/2010 | US7786162 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof |
08/31/2010 | US7786147 used for the treatment of Parkinson's disease, Huntington disease, Alzheimer's disease, amyotrophic lateral sclerosis, spinal muscular atrophy, ataxia, Pick's disease, Pick's disease, vision defects, Cruetzfelt-Jacob syndrome or Alzheimer's disease |
08/31/2010 | US7786140 Piperidine derivative having NMDA receptor antagonistic activity |
08/31/2010 | US7786135 Substituted pyrroline kinase inhibitors |
08/31/2010 | US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example |
08/31/2010 | US7786105 e.g. 1-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]-4-[3-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)propyl]piperazin-4-ium chloride3,4-Dihydroquinolin-2(1H)-one; dopamine D3 receptor antagonists or agonists; antidepressant, schizophrenia, Parkinson's disease |
08/31/2010 | US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
08/31/2010 | US7785886 Contacting ABC1-expressing cells with a composition containing test compound and measuring biological activity by determining the level of efflux of labeled substrate ; use in treating cardiovascular disease |
08/31/2010 | US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
08/31/2010 | US7785833 Methods and means for producing proteins with predetermined post-translational modifications |
08/31/2010 | US7785819 Diagnosis of autoimmune disease; generate solid support, incubate with fluid sample, detect preferential antigens, compare to control, evaluate for autoimmune diseases |
08/31/2010 | US7785804 Mammalian CX3C chemokine antibodies |
08/31/2010 | US7785622 comprises fentanyl as active ingredient, pressure-sensitive adhesive base, and tackifier resin; pressure-sensitive adhesive base comprising polyisobutylene and styrene/isoprene/styrene block copolymer; easily produced, has long-term continuity, and is excellent in adhesion and conformability to skin |
08/31/2010 | US7785601 administering a hematopoietic growth factor such as granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor to a mammal |
08/31/2010 | US7785599 Albumin fusion proteins |
08/31/2010 | US7785596 administering galectins to the brain of the vertebrates to intensify in vivo proliferation of subventricular zone astrocytes and neuron stem cells; treatment of neurodegenerative diseases, brain and nervous system disorders |
08/31/2010 | CA2603274C Tetracyclic compounds, their preparation process and the pharmaceutical compounds containing them |
08/31/2010 | CA2567981C Constrained himbacine analogs as thrombin receptor antagonists |
08/31/2010 | CA2473152C Orally dispersible pharmaceutical piribedil composition |
08/31/2010 | CA2397723C Brain, spinal and nerve injury treatment |
08/31/2010 | CA2389545C Chemokine receptor binding heterocyclic compounds |
08/31/2010 | CA2374226C Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives |
08/31/2010 | CA2364493C Nitrate esters and their use for neurological conditions |
08/31/2010 | CA2262010C Hsv strain lacking functional icp27 and icp34.5 genes |
08/31/2010 | CA2227235C Novel galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
08/26/2010 | WO2010096791A1 (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
08/26/2010 | WO2010096778A1 Methods of and compositions for reducing cell death |
08/26/2010 | WO2010096751A1 Compositions and methods for treating a disease mediated by soluble oligomeric amyloid beta |
08/26/2010 | WO2010096470A2 Method for inhibiting neurodegeneration |
08/26/2010 | WO2010096389A1 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase |
08/26/2010 | WO2010096384A2 Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands |
08/26/2010 | WO2010096371A2 Heterocyclic compounds which modulate the cb2 receptor |
08/26/2010 | WO2010096134A1 Extended length botulinum toxin formulation for human or mammalian use |
08/26/2010 | WO2010096045A1 Novel and potent tapentadol dosage forms |
08/26/2010 | WO2010096011A1 Cyclopropyl amide derivatives targeting the histamine h3 receptor |
08/26/2010 | WO2010095943A2 Use of resveratrol or another hydroxylated stilbene for preserving cognitive functioning |
08/26/2010 | WO2010095940A2 Glutathione-based drug delivery system |
08/26/2010 | WO2010095926A1 Use of reveratrol for preserving cognitive functioning |
08/26/2010 | WO2010095741A1 Novel steroid derivative and process for production thereof, and pharmaceutical preparation comprising the novel steroid derivative |
08/26/2010 | WO2010095663A1 Fused heterocyclic ring compound |
08/26/2010 | WO2010095462A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same |
08/26/2010 | WO2010095304A1 Hydrogel of polysaccharide derivatives |
08/26/2010 | WO2010095106A1 Solid forms of ( 2r) -2- { ( is ) -6, 7 -dimethoxy- 1- [2- (4-triflu0r0methyl-phenyl) -ethyl] -3, 4-dihydr0-1h -isoquinolin-2-yl} -n-methyl-2-phenyl-acetamide hydrochloride |
08/26/2010 | WO2010094762A1 Heteroaryl substituted pyridazinone derivatives |
08/26/2010 | WO2010094755A1 Carboxamide compounds and their use as calpain inhibitors |
08/26/2010 | WO2010094669A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives |
08/26/2010 | WO2010094667A1 Pyrrolidine derivatives as nk3 receptor antagonists |
08/26/2010 | WO2010094659A1 Amine or amino alcohols as glyt1 inhibitors |
08/26/2010 | WO2010094647A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators |
08/26/2010 | WO2010094645A1 Substituted pyridine derivatives and their medical use |
08/26/2010 | WO2010094644A1 Substituted pyridine derivatives and their medical use |
08/26/2010 | WO2010094289A1 Allosteric binding compounds |
08/26/2010 | WO2010094242A1 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
08/26/2010 | WO2010094074A1 Pharmaceutical preparation and delivery system |
08/26/2010 | WO2010076524A3 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators |
08/26/2010 | WO2010073104A3 Improving cognitive function |
08/26/2010 | WO2010056988A9 Methods of treating stroke using stem cell-like menstrual blood cells |
08/26/2010 | WO2007039781A3 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors |
08/26/2010 | US20100217727 Dopamine Transporter Inhibitors for Use in Treatment of Movement Disorders and Other CNS Indications |
08/26/2010 | US20100216976 Sodium-independent transporter carrying acidic amino acid and its gene |
08/26/2010 | US20100216878 Amino Acid Derivatives |
08/26/2010 | US20100216875 Methods of treating alzheimer's disease |
08/26/2010 | US20100216871 Use of compounds having ccr antagonism |
08/26/2010 | US20100216868 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial |
08/26/2010 | US20100216862 Pyrrole Derivatives As Therapeutic Compounds |
08/26/2010 | US20100216861 Amino arylsulfonamide compounds and their use as 5-ht6 ligands |
08/26/2010 | US20100216857 Method of treating motor disorders with 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione |
08/26/2010 | US20100216855 Imidazaolone derivatives,preparation thereof and biological use of same |
08/26/2010 | US20100216846 Trisubstituted 1,2,4 triazoles |
08/26/2010 | US20100216844 Carboxamide compounds and their use as calpain inhibitors |
08/26/2010 | US20100216842 Narcotic Emulsion Formulations for Treatment of Cancer Pain |
08/26/2010 | US20100216841 4-Fluoro-Piperidine T-Type Calcium Channel Antagonists |
08/26/2010 | US20100216840 Benzimidazolidinone derivatives as muscarinic agents |
08/26/2010 | US20100216837 Glycine transport inhibitors |
08/26/2010 | US20100216836 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases |
08/26/2010 | US20100216833 Tetrahydrocarbazoles and derivatives |